Trauma Fixation Device Research Report and Company Analysis 2024-2032 Featuring Zimmer Biomet, Orthofix Medical, B. Braun Meslungen, Stryker, Medtronic, Smith & Nephew, Integra LifeSciences, & Otto - ResearchAndMarkets.com
Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $21
Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024
Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating
Daiwa Heavy Report: Will brain-computer interface be the next major medical technology opportunity?
It is stated by DaMo that BCI technology may become an important breakthrough in future medical technology, providing new treatment options for nearly 10 million BCI candidates (patients with neurological diseases), and bringing about a $400 billion market opportunity.
Express News | Honda will recall about 1.7 million autos in the USA.